Drug Lifecycle Intelligence 360
Complete lifecycle intelligence from first submission to patent expiry, label change, safety signal, and competitor entry.
The problem this solves
Life sciences teams need decisions faster than public data can be cleaned manually. This solution compresses months of preparation into a governed, query-ready product.
VP-level and director-level teams often know which questions matter, but the required data is spread across incompatible FDA, CMS, NIH, EMA, USPTO, literature, ontology, and identity sources.
Drug Lifecycle Intelligence 360 removes the repeated engineering work by delivering the connected tables, bridge keys, and sample queries that your team would otherwise build from scratch.
What you get
Submission, approval, label, safety, patent, exclusivity, and EMA facts joined to the same drug identity.
Timeline fields for first approval, latest label change, REMS burden, market-access signal, and LOE runway.
Mechanism and target links that connect clinical and regulatory lifecycle events to biology.
Portfolio comparison-ready tables for lifecycle management and competitive intelligence.
Context Layers Powering This Solution
Each card links to a query-ready context layer in the biomedical estate.
Approval pathways, review history, and regulatory status
Regulatory layer • 400K+ • Monthly
Regulatory contextCurrent prescribing context, warnings, indications, and dosing
Regulatory layer • 54K+ active labels • Weekly
Regulatory contextLabel-change history and regulatory event timeline
Regulatory layer • 140K+ versions • Monthly
Regulatory contextPost-market adverse-event signals and safety reporting context
Regulatory layer • 25M+ reports • Quarterly
Regulatory contextRisk-management requirements and safety-burden context
Regulatory layer • 400+ programs • Monthly
Clinical contextEuropean authorization and dual-market context
Clinical layer • 1,500+ products • Monthly
IP & Patent contextListed patent runway and challenge context
IP & Patent layer • 15K+ patents • Monthly
IP & Patent contextRegulatory exclusivity shield context
IP & Patent layer • 8K+ exclusivity entries • Monthly
Scientific contextDrug-target mechanism and bioactivity context
Scientific layer • 2.5M compounds • Quarterly
Scientific contextHuman protein target biology context
Scientific layer • 20,370 human proteins • Quarterly
Financial & Market Access contextMedicare pharmacy-channel spend and exposure context
Financial & Market Access layer • 5K+ drugs • Annual
Day-one query results for semaglutide
Designed sample output showing the type of redacted table your analysts can query immediately after provisioning.
| Signal | Value | Source |
|---|---|---|
| Canonical entity | semaglutide | Drug spine |
| Primary risk score | High confidence | Pre-computed model |
| Connected products | 11 products | TDD catalog |
| Latest refresh | 2026-09-01 | Lineage table |
Built for the teams who own the decision
For Competitive intelligence teams
Track label expansions, safety restrictions, competitor approvals, and biosimilar activity across a class.
For Lifecycle management teams
Identify windows for indication expansion, reformulation, REMS mitigation, and LOE defense.
For Regulatory strategy teams
Compare pathway, submission, and label change histories for analog products.
Common questions
Procurement, architecture, and analytics teams can evaluate exactly how the product will land in your environment.
Query on day one
Sample SQL included
Does Lifecycle 360 include both FDA and EMA context?
Yes. EMA authorized products are bridged to FDA drug identities where exact matching is possible.
Can we monitor label change velocity?
Yes. Historical SPL records are versioned so warning, indication, and adverse-reaction changes can be tracked over time.
How quickly is the product available?
A governed BigQuery or Snowflake delivery can be provisioned in less than 24 hours after access approval.
See This Solution In Action
We'll walk through live warehouse queries and sample outputs for your specific use case.
Request Demo